BiondVax Pharmaceuticals Ltd.
BVXVW
BVXVW was delisted on the 13th of May, 2020.
2 hedge funds and large institutions have $8K invested in BiondVax Pharmaceuticals Ltd. in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
50% less funds holding
Funds holding: 4 → 2 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
97% less capital invested
Capital invested by funds: $252K → $8K (-$244K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWM
Focused Wealth Management
Newburgh,
New York
|
+$23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$189K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$24.5K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $5K | -$24.5K | -8,641 | -41% |
|
|
FWM
2
Focused Wealth Management
Newburgh,
New York
| $3K | +$23K | +8,107 | New |
|
|
CH
3
CVI Holdings
Wilmington,
Delaware
| – | -$189K | -72,800 | Closed |
|
|
4
Bank of America
Charlotte,
North Carolina
| – | -$5K | -2,000 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$3K | -1,179 | Closed |
|
BVXVW Hedge Fund Activity: Q1 2020 in Review
2 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in BiondVax Pharmaceuticals Ltd. (BVXVW) for Q1 2020, worth a combined $8K — down 97% from $252K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BVXVW and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Focused Wealth Management, opening a new position worth an estimated $23K. The largest seller was CVI Holdings, exiting entirely with an estimated $189K sold.
- 2 institutional investors held BiondVax Pharmaceuticals Ltd. (BVXVW) as of Q1 2020, down from 4 in Q4 2019.
- Funds reported $8K of BiondVax Pharmaceuticals Ltd. stock for Q1 2020, down 97% quarter-over-quarter.
- 1 fund opened new BiondVax Pharmaceuticals Ltd. positions in Q1 2020 and 3 closed out, a net change of -2 holders.
- The largest BiondVax Pharmaceuticals Ltd. buyer in Q1 2020 was Focused Wealth Management, an estimated $23K added.
- The largest BiondVax Pharmaceuticals Ltd. seller in Q1 2020 was CVI Holdings, an estimated $189K sold.
Based on aggregated 13F filings for Q1 2020.